nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—ABCB1—peripheral nervous system neoplasm	0.142	1	CbGaD
Cyclosporine—ABCC10—Vincristine—peripheral nervous system neoplasm	0.04	0.0691	CbGbCtD
Cyclosporine—ABCC10—Etoposide—peripheral nervous system neoplasm	0.0367	0.0633	CbGbCtD
Cyclosporine—ABCC3—Vincristine—peripheral nervous system neoplasm	0.0252	0.0434	CbGbCtD
Cyclosporine—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0251	0.0433	CbGbCtD
Cyclosporine—ABCC10—Doxorubicin—peripheral nervous system neoplasm	0.025	0.0432	CbGbCtD
Cyclosporine—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0242	0.0418	CbGbCtD
Cyclosporine—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.0235	0.0405	CbGbCtD
Cyclosporine—ABCC3—Etoposide—peripheral nervous system neoplasm	0.0231	0.0398	CbGbCtD
Cyclosporine—ABCB11—Vincristine—peripheral nervous system neoplasm	0.0218	0.0376	CbGbCtD
Cyclosporine—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0182	0.0314	CbGbCtD
Cyclosporine—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0168	0.029	CbGbCtD
Cyclosporine—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0166	0.0287	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0166	0.0287	CbGbCtD
Cyclosporine—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.0157	0.0272	CbGbCtD
Cyclosporine—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0155	0.0267	CbGbCtD
Cyclosporine—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0142	0.0244	CbGbCtD
Cyclosporine—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.0136	0.0235	CbGbCtD
Cyclosporine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0125	0.0215	CbGbCtD
Cyclosporine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.012	0.0207	CbGbCtD
Cyclosporine—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0114	0.0197	CbGbCtD
Cyclosporine—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0107	0.0184	CbGbCtD
Cyclosporine—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0105	0.0181	CbGbCtD
Cyclosporine—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0103	0.0179	CbGbCtD
Cyclosporine—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.00966	0.0167	CbGbCtD
Cyclosporine—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.00965	0.0166	CbGbCtD
Cyclosporine—ABCG2—Etoposide—peripheral nervous system neoplasm	0.00948	0.0164	CbGbCtD
Cyclosporine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.00874	0.0151	CbGbCtD
Cyclosporine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.00874	0.0151	CbGbCtD
Cyclosporine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.00837	0.0144	CbGbCtD
Cyclosporine—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.00764	0.0132	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.00764	0.0132	CbGbCtD
Cyclosporine—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.00715	0.0123	CbGbCtD
Cyclosporine—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00647	0.0112	CbGbCtD
Cyclosporine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00606	0.0105	CbGbCtD
Cyclosporine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.00573	0.00989	CbGbCtD
Cyclosporine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00525	0.00906	CbGbCtD
Cyclosporine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00524	0.00903	CbGbCtD
Cyclosporine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00505	0.00871	CbGbCtD
Cyclosporine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00487	0.0084	CbGbCtD
Cyclosporine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00373	0.00644	CbGbCtD
Cyclosporine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00358	0.00619	CbGbCtD
Cyclosporine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00348	0.006	CbGbCtD
Cyclosporine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00342	0.0059	CbGbCtD
Cyclosporine—PPP3CA—pons—peripheral nervous system neoplasm	0.00328	0.137	CbGeAlD
Cyclosporine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00233	0.00402	CbGbCtD
Cyclosporine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00224	0.00386	CbGbCtD
Cyclosporine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0022	0.00379	CbGbCtD
Cyclosporine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00205	0.00353	CbGbCtD
Cyclosporine—PPP3CA—ganglion—peripheral nervous system neoplasm	0.00168	0.0704	CbGeAlD
Cyclosporine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0014	0.00241	CbGbCtD
Cyclosporine—PPID—trigeminal ganglion—peripheral nervous system neoplasm	0.00119	0.0497	CbGeAlD
Cyclosporine—CAMLG—trigeminal ganglion—peripheral nervous system neoplasm	0.00117	0.049	CbGeAlD
Cyclosporine—PPID—parotid gland—peripheral nervous system neoplasm	0.00112	0.0468	CbGeAlD
Cyclosporine—CAMLG—parotid gland—peripheral nervous system neoplasm	0.0011	0.0462	CbGeAlD
Cyclosporine—PPIA—trigeminal ganglion—peripheral nervous system neoplasm	0.00107	0.0446	CbGeAlD
Cyclosporine—CAMLG—brainstem—peripheral nervous system neoplasm	0.00104	0.0433	CbGeAlD
Cyclosporine—PPIF—trigeminal ganglion—peripheral nervous system neoplasm	0.000863	0.0361	CbGeAlD
Cyclosporine—FKBP1B—cerebellum—peripheral nervous system neoplasm	0.000848	0.0355	CbGeAlD
Cyclosporine—PPP3CA—trigeminal ganglion—peripheral nervous system neoplasm	0.000826	0.0346	CbGeAlD
Cyclosporine—PPIB—trigeminal ganglion—peripheral nervous system neoplasm	0.000821	0.0344	CbGeAlD
Cyclosporine—PPP3CA—parotid gland—peripheral nervous system neoplasm	0.000779	0.0326	CbGeAlD
Cyclosporine—PPIB—parotid gland—peripheral nervous system neoplasm	0.000774	0.0324	CbGeAlD
Cyclosporine—PPP3CA—brainstem—peripheral nervous system neoplasm	0.000731	0.0306	CbGeAlD
Cyclosporine—FKBP4—cerebellum—peripheral nervous system neoplasm	0.000561	0.0235	CbGeAlD
Cyclosporine—FKBP1A—trigeminal ganglion—peripheral nervous system neoplasm	0.000549	0.023	CbGeAlD
Cyclosporine—PPID—cerebellum—peripheral nervous system neoplasm	0.000518	0.0217	CbGeAlD
Cyclosporine—CAMLG—cerebellum—peripheral nervous system neoplasm	0.00051	0.0214	CbGeAlD
Cyclosporine—PPIA—cerebellum—peripheral nervous system neoplasm	0.000465	0.0195	CbGeAlD
Cyclosporine—ABCC10—trigeminal ganglion—peripheral nervous system neoplasm	0.00044	0.0184	CbGeAlD
Cyclosporine—ABCC10—parotid gland—peripheral nervous system neoplasm	0.000415	0.0174	CbGeAlD
Cyclosporine—PPIF—cerebellum—peripheral nervous system neoplasm	0.000376	0.0158	CbGeAlD
Cyclosporine—PPP3CA—cerebellum—peripheral nervous system neoplasm	0.00036	0.0151	CbGeAlD
Cyclosporine—PPIB—cerebellum—peripheral nervous system neoplasm	0.000358	0.015	CbGeAlD
Cyclosporine—ABCC1—parotid gland—peripheral nervous system neoplasm	0.000293	0.0123	CbGeAlD
Cyclosporine—ABCG2—trigeminal ganglion—peripheral nervous system neoplasm	0.000257	0.0108	CbGeAlD
Cyclosporine—ABCG2—parotid gland—peripheral nervous system neoplasm	0.000243	0.0102	CbGeAlD
Cyclosporine—FKBP1A—cerebellum—peripheral nervous system neoplasm	0.000239	0.01	CbGeAlD
Cyclosporine—ABCC10—cerebellum—peripheral nervous system neoplasm	0.000192	0.00803	CbGeAlD
Cyclosporine—SLCO1A2—cerebellum—peripheral nervous system neoplasm	0.000165	0.00692	CbGeAlD
Cyclosporine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000156	0.00654	CbGeAlD
Cyclosporine—ABCC1—cerebellum—peripheral nervous system neoplasm	0.000136	0.00568	CbGeAlD
Cyclosporine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000127	0.00531	CbGeAlD
Cyclosporine—ABCG2—cerebellum—peripheral nervous system neoplasm	0.000112	0.0047	CbGeAlD
Cyclosporine—CYP2D6—cerebellum—peripheral nervous system neoplasm	7.7e-05	0.00322	CbGeAlD
Cyclosporine—ABCB1—cerebellum—peripheral nervous system neoplasm	5.54e-05	0.00232	CbGeAlD
Cyclosporine—Gastritis—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000286	CcSEcCtD
Cyclosporine—Pain—Cisplatin—peripheral nervous system neoplasm	5.35e-05	0.000286	CcSEcCtD
Cyclosporine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.000286	CcSEcCtD
Cyclosporine—Dysuria—Epirubicin—peripheral nervous system neoplasm	5.29e-05	0.000283	CcSEcCtD
Cyclosporine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	5.27e-05	0.000282	CcSEcCtD
Cyclosporine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	5.27e-05	0.000282	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.000281	CcSEcCtD
Cyclosporine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	5.23e-05	0.00028	CcSEcCtD
Cyclosporine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	5.22e-05	0.000279	CcSEcCtD
Cyclosporine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	5.22e-05	0.000279	CcSEcCtD
Cyclosporine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	5.2e-05	0.000278	CcSEcCtD
Cyclosporine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	5.16e-05	0.000276	CcSEcCtD
Cyclosporine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	5.15e-05	0.000275	CcSEcCtD
Cyclosporine—Weight increased—Epirubicin—peripheral nervous system neoplasm	5.15e-05	0.000275	CcSEcCtD
Cyclosporine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	5.13e-05	0.000274	CcSEcCtD
Cyclosporine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	5.11e-05	0.000274	CcSEcCtD
Cyclosporine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	5.11e-05	0.000273	CcSEcCtD
Cyclosporine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	5.1e-05	0.000273	CcSEcCtD
Cyclosporine—Somnolence—Etoposide—peripheral nervous system neoplasm	5.1e-05	0.000273	CcSEcCtD
Cyclosporine—Asthenia—Vincristine—peripheral nervous system neoplasm	5.08e-05	0.000272	CcSEcCtD
Cyclosporine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	5.07e-05	0.000271	CcSEcCtD
Cyclosporine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.00027	CcSEcCtD
Cyclosporine—Infestation—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.00027	CcSEcCtD
Cyclosporine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	5.04e-05	0.000269	CcSEcCtD
Cyclosporine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000269	CcSEcCtD
Cyclosporine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	5.03e-05	0.000269	CcSEcCtD
Cyclosporine—Rash—Dactinomycin—peripheral nervous system neoplasm	5e-05	0.000267	CcSEcCtD
Cyclosporine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	4.99e-05	0.000267	CcSEcCtD
Cyclosporine—Renal failure—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000265	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	4.95e-05	0.000265	CcSEcCtD
Cyclosporine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	4.95e-05	0.000265	CcSEcCtD
Cyclosporine—Fatigue—Etoposide—peripheral nervous system neoplasm	4.94e-05	0.000264	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	4.94e-05	0.000264	CcSEcCtD
Cyclosporine—Jaundice—Epirubicin—peripheral nervous system neoplasm	4.91e-05	0.000263	CcSEcCtD
Cyclosporine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	4.91e-05	0.000263	CcSEcCtD
Cyclosporine—Pain—Etoposide—peripheral nervous system neoplasm	4.9e-05	0.000262	CcSEcCtD
Cyclosporine—Constipation—Etoposide—peripheral nervous system neoplasm	4.9e-05	0.000262	CcSEcCtD
Cyclosporine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	4.9e-05	0.000262	CcSEcCtD
Cyclosporine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	4.9e-05	0.000262	CcSEcCtD
Cyclosporine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.000262	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	4.86e-05	0.00026	CcSEcCtD
Cyclosporine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.86e-05	0.00026	CcSEcCtD
Cyclosporine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.84e-05	0.000259	CcSEcCtD
Cyclosporine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.000258	CcSEcCtD
Cyclosporine—Haematuria—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000257	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000255	CcSEcCtD
Cyclosporine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	4.76e-05	0.000255	CcSEcCtD
Cyclosporine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	4.75e-05	0.000254	CcSEcCtD
Cyclosporine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	4.73e-05	0.000253	CcSEcCtD
Cyclosporine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000253	CcSEcCtD
Cyclosporine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.73e-05	0.000253	CcSEcCtD
Cyclosporine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	4.72e-05	0.000252	CcSEcCtD
Cyclosporine—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.71e-05	0.000252	CcSEcCtD
Cyclosporine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000251	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.69e-05	0.000251	CcSEcCtD
Cyclosporine—Dizziness—Vincristine—peripheral nervous system neoplasm	4.68e-05	0.00025	CcSEcCtD
Cyclosporine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.67e-05	0.00025	CcSEcCtD
Cyclosporine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	4.66e-05	0.000249	CcSEcCtD
Cyclosporine—Infestation—Doxorubicin—peripheral nervous system neoplasm	4.66e-05	0.000249	CcSEcCtD
Cyclosporine—Rash—Alitretinoin—peripheral nervous system neoplasm	4.63e-05	0.000248	CcSEcCtD
Cyclosporine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.63e-05	0.000248	CcSEcCtD
Cyclosporine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.61e-05	0.000247	CcSEcCtD
Cyclosporine—Headache—Alitretinoin—peripheral nervous system neoplasm	4.6e-05	0.000246	CcSEcCtD
Cyclosporine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000245	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.57e-05	0.000245	CcSEcCtD
Cyclosporine—Urticaria—Etoposide—peripheral nervous system neoplasm	4.56e-05	0.000244	CcSEcCtD
Cyclosporine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000243	CcSEcCtD
Cyclosporine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.55e-05	0.000243	CcSEcCtD
Cyclosporine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	4.55e-05	0.000243	CcSEcCtD
Cyclosporine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.54e-05	0.000243	CcSEcCtD
Cyclosporine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.53e-05	0.000242	CcSEcCtD
Cyclosporine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.53e-05	0.000242	CcSEcCtD
Cyclosporine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	4.53e-05	0.000242	CcSEcCtD
Cyclosporine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	4.53e-05	0.000242	CcSEcCtD
Cyclosporine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.53e-05	0.000242	CcSEcCtD
Cyclosporine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	4.53e-05	0.000242	CcSEcCtD
Cyclosporine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000241	CcSEcCtD
Cyclosporine—Vomiting—Vincristine—peripheral nervous system neoplasm	4.5e-05	0.000241	CcSEcCtD
Cyclosporine—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.49e-05	0.00024	CcSEcCtD
Cyclosporine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.00024	CcSEcCtD
Cyclosporine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	4.47e-05	0.000239	CcSEcCtD
Cyclosporine—Rash—Vincristine—peripheral nervous system neoplasm	4.46e-05	0.000239	CcSEcCtD
Cyclosporine—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.46e-05	0.000239	CcSEcCtD
Cyclosporine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000238	CcSEcCtD
Cyclosporine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	4.45e-05	0.000238	CcSEcCtD
Cyclosporine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	4.44e-05	0.000237	CcSEcCtD
Cyclosporine—Headache—Vincristine—peripheral nervous system neoplasm	4.44e-05	0.000237	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	0.000236	CcSEcCtD
Cyclosporine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.000235	CcSEcCtD
Cyclosporine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000234	CcSEcCtD
Cyclosporine—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.36e-05	0.000233	CcSEcCtD
Cyclosporine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.000233	CcSEcCtD
Cyclosporine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.28e-05	0.000229	CcSEcCtD
Cyclosporine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	4.23e-05	0.000226	CcSEcCtD
Cyclosporine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	4.22e-05	0.000226	CcSEcCtD
Cyclosporine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000225	CcSEcCtD
Cyclosporine—Nausea—Vincristine—peripheral nervous system neoplasm	4.21e-05	0.000225	CcSEcCtD
Cyclosporine—Flushing—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000225	CcSEcCtD
Cyclosporine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	4.2e-05	0.000225	CcSEcCtD
Cyclosporine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000224	CcSEcCtD
Cyclosporine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000224	CcSEcCtD
Cyclosporine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000223	CcSEcCtD
Cyclosporine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000222	CcSEcCtD
Cyclosporine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.000221	CcSEcCtD
Cyclosporine—Asthenia—Etoposide—peripheral nervous system neoplasm	4.11e-05	0.00022	CcSEcCtD
Cyclosporine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.00022	CcSEcCtD
Cyclosporine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	4.11e-05	0.00022	CcSEcCtD
Cyclosporine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.00022	CcSEcCtD
Cyclosporine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	4.08e-05	0.000218	CcSEcCtD
Cyclosporine—Chills—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000217	CcSEcCtD
Cyclosporine—Pruritus—Etoposide—peripheral nervous system neoplasm	4.06e-05	0.000217	CcSEcCtD
Cyclosporine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	4.04e-05	0.000216	CcSEcCtD
Cyclosporine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.000216	CcSEcCtD
Cyclosporine—Alopecia—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000214	CcSEcCtD
Cyclosporine—Vomiting—Cisplatin—peripheral nervous system neoplasm	3.98e-05	0.000213	CcSEcCtD
Cyclosporine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	3.96e-05	0.000212	CcSEcCtD
Cyclosporine—Rash—Cisplatin—peripheral nervous system neoplasm	3.95e-05	0.000211	CcSEcCtD
Cyclosporine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	3.94e-05	0.000211	CcSEcCtD
Cyclosporine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	3.94e-05	0.000211	CcSEcCtD
Cyclosporine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	3.92e-05	0.00021	CcSEcCtD
Cyclosporine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	3.9e-05	0.000209	CcSEcCtD
Cyclosporine—Flushing—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000208	CcSEcCtD
Cyclosporine—Flatulence—Epirubicin—peripheral nervous system neoplasm	3.88e-05	0.000208	CcSEcCtD
Cyclosporine—Tension—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000207	CcSEcCtD
Cyclosporine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	3.86e-05	0.000206	CcSEcCtD
Cyclosporine—Nervousness—Epirubicin—peripheral nervous system neoplasm	3.83e-05	0.000205	CcSEcCtD
Cyclosporine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000203	CcSEcCtD
Cyclosporine—Dizziness—Etoposide—peripheral nervous system neoplasm	3.79e-05	0.000203	CcSEcCtD
Cyclosporine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.79e-05	0.000203	CcSEcCtD
Cyclosporine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.77e-05	0.000202	CcSEcCtD
Cyclosporine—Chills—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.000201	CcSEcCtD
Cyclosporine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	3.74e-05	0.0002	CcSEcCtD
Cyclosporine—Nausea—Cisplatin—peripheral nervous system neoplasm	3.72e-05	0.000199	CcSEcCtD
Cyclosporine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	3.71e-05	0.000199	CcSEcCtD
Cyclosporine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000198	CcSEcCtD
Cyclosporine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	3.67e-05	0.000196	CcSEcCtD
Cyclosporine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.65e-05	0.000195	CcSEcCtD
Cyclosporine—Vomiting—Etoposide—peripheral nervous system neoplasm	3.65e-05	0.000195	CcSEcCtD
Cyclosporine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	3.64e-05	0.000195	CcSEcCtD
Cyclosporine—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.64e-05	0.000195	CcSEcCtD
Cyclosporine—Agitation—Epirubicin—peripheral nervous system neoplasm	3.62e-05	0.000194	CcSEcCtD
Cyclosporine—Rash—Etoposide—peripheral nervous system neoplasm	3.62e-05	0.000193	CcSEcCtD
Cyclosporine—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.61e-05	0.000193	CcSEcCtD
Cyclosporine—Headache—Etoposide—peripheral nervous system neoplasm	3.59e-05	0.000192	CcSEcCtD
Cyclosporine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	3.59e-05	0.000192	CcSEcCtD
Cyclosporine—Tension—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000191	CcSEcCtD
Cyclosporine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	3.57e-05	0.000191	CcSEcCtD
Cyclosporine—Malaise—Epirubicin—peripheral nervous system neoplasm	3.55e-05	0.00019	CcSEcCtD
Cyclosporine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	3.54e-05	0.000189	CcSEcCtD
Cyclosporine—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.54e-05	0.000189	CcSEcCtD
Cyclosporine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.53e-05	0.000189	CcSEcCtD
Cyclosporine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.5e-05	0.000187	CcSEcCtD
Cyclosporine—Cough—Epirubicin—peripheral nervous system neoplasm	3.44e-05	0.000184	CcSEcCtD
Cyclosporine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	3.44e-05	0.000184	CcSEcCtD
Cyclosporine—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.41e-05	0.000183	CcSEcCtD
Cyclosporine—Nausea—Etoposide—peripheral nervous system neoplasm	3.41e-05	0.000182	CcSEcCtD
Cyclosporine—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.4e-05	0.000182	CcSEcCtD
Cyclosporine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.38e-05	0.000181	CcSEcCtD
Cyclosporine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.37e-05	0.00018	CcSEcCtD
Cyclosporine—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.35e-05	0.000179	CcSEcCtD
Cyclosporine—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.35e-05	0.000179	CcSEcCtD
Cyclosporine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.35e-05	0.000179	CcSEcCtD
Cyclosporine—Agitation—Doxorubicin—peripheral nervous system neoplasm	3.35e-05	0.000179	CcSEcCtD
Cyclosporine—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.34e-05	0.000179	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000178	CcSEcCtD
Cyclosporine—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.000177	CcSEcCtD
Cyclosporine—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.29e-05	0.000176	CcSEcCtD
Cyclosporine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	3.28e-05	0.000175	CcSEcCtD
Cyclosporine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.27e-05	0.000175	CcSEcCtD
Cyclosporine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.26e-05	0.000175	CcSEcCtD
Cyclosporine—Confusional state—Epirubicin—peripheral nervous system neoplasm	3.24e-05	0.000173	CcSEcCtD
Cyclosporine—Oedema—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000172	CcSEcCtD
Cyclosporine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000172	CcSEcCtD
Cyclosporine—Infection—Epirubicin—peripheral nervous system neoplasm	3.19e-05	0.000171	CcSEcCtD
Cyclosporine—Cough—Doxorubicin—peripheral nervous system neoplasm	3.18e-05	0.00017	CcSEcCtD
Cyclosporine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	3.16e-05	0.000169	CcSEcCtD
Cyclosporine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	3.15e-05	0.000169	CcSEcCtD
Cyclosporine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.15e-05	0.000168	CcSEcCtD
Cyclosporine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000168	CcSEcCtD
Cyclosporine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	3.12e-05	0.000167	CcSEcCtD
Cyclosporine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	3.11e-05	0.000166	CcSEcCtD
Cyclosporine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	3.1e-05	0.000166	CcSEcCtD
Cyclosporine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	3.1e-05	0.000166	CcSEcCtD
Cyclosporine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.1e-05	0.000166	CcSEcCtD
Cyclosporine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	3.09e-05	0.000165	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000165	CcSEcCtD
Cyclosporine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000164	CcSEcCtD
Cyclosporine—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.06e-05	0.000164	CcSEcCtD
Cyclosporine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000162	CcSEcCtD
Cyclosporine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	3e-05	0.00016	CcSEcCtD
Cyclosporine—Oedema—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.000159	CcSEcCtD
Cyclosporine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.000159	CcSEcCtD
Cyclosporine—Infection—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000158	CcSEcCtD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.93e-05	0.000436	CbGpPWpGaD
Cyclosporine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.93e-05	0.000157	CcSEcCtD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.92e-05	0.000435	CbGpPWpGaD
Cyclosporine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.92e-05	0.000156	CcSEcCtD
Cyclosporine—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.91e-05	0.000434	CbGpPWpGaD
Cyclosporine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.000156	CcSEcCtD
Cyclosporine—SLC10A1—Metabolism—TH—peripheral nervous system neoplasm	2.91e-05	0.000433	CbGpPWpGaD
Cyclosporine—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.91e-05	0.000156	CcSEcCtD
Cyclosporine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	2.89e-05	0.000155	CcSEcCtD
Cyclosporine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.89e-05	0.000154	CcSEcCtD
Cyclosporine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.88e-05	0.000154	CcSEcCtD
Cyclosporine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.87e-05	0.000153	CcSEcCtD
Cyclosporine—ABCC3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.87e-05	0.000426	CbGpPWpGaD
Cyclosporine—Somnolence—Epirubicin—peripheral nervous system neoplasm	2.86e-05	0.000153	CcSEcCtD
Cyclosporine—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	2.85e-05	0.000424	CbGpPWpGaD
Cyclosporine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.84e-05	0.000152	CcSEcCtD
Cyclosporine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.83e-05	0.000151	CcSEcCtD
Cyclosporine—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.82e-05	0.00042	CbGpPWpGaD
Cyclosporine—ABCC3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.81e-05	0.000418	CbGpPWpGaD
Cyclosporine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.79e-05	0.000149	CcSEcCtD
Cyclosporine—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.79e-05	0.000415	CbGpPWpGaD
Cyclosporine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.78e-05	0.000148	CcSEcCtD
Cyclosporine—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.77e-05	0.000148	CcSEcCtD
Cyclosporine—Pain—Epirubicin—peripheral nervous system neoplasm	2.75e-05	0.000147	CcSEcCtD
Cyclosporine—Constipation—Epirubicin—peripheral nervous system neoplasm	2.75e-05	0.000147	CcSEcCtD
Cyclosporine—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	2.74e-05	0.000408	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	2.72e-05	0.000404	CbGpPWpGaD
Cyclosporine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.71e-05	0.000145	CcSEcCtD
Cyclosporine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.69e-05	0.000144	CcSEcCtD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.68e-05	0.000399	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	2.68e-05	0.000398	CbGpPWpGaD
Cyclosporine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.67e-05	0.000143	CcSEcCtD
Cyclosporine—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.67e-05	0.000397	CbGpPWpGaD
Cyclosporine—PPIA—Disease—PTPN11—peripheral nervous system neoplasm	2.66e-05	0.000396	CbGpPWpGaD
Cyclosporine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.65e-05	0.000142	CcSEcCtD
Cyclosporine—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.65e-05	0.000395	CbGpPWpGaD
Cyclosporine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.65e-05	0.000142	CcSEcCtD
Cyclosporine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.64e-05	0.000141	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.63e-05	0.000141	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.62e-05	0.00039	CbGpPWpGaD
Cyclosporine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.62e-05	0.00014	CcSEcCtD
Cyclosporine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.61e-05	0.000388	CbGpPWpGaD
Cyclosporine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.59e-05	0.000138	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	2.58e-05	0.000384	CbGpPWpGaD
Cyclosporine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.57e-05	0.000137	CcSEcCtD
Cyclosporine—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	2.57e-05	0.000382	CbGpPWpGaD
Cyclosporine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.56e-05	0.000137	CcSEcCtD
Cyclosporine—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.55e-05	0.000137	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.55e-05	0.000379	CbGpPWpGaD
Cyclosporine—Pain—Doxorubicin—peripheral nervous system neoplasm	2.54e-05	0.000136	CcSEcCtD
Cyclosporine—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.54e-05	0.000136	CcSEcCtD
Cyclosporine—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	2.54e-05	0.000378	CbGpPWpGaD
Cyclosporine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.54e-05	0.000136	CcSEcCtD
Cyclosporine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.54e-05	0.000136	CcSEcCtD
Cyclosporine—PPIA—Hemostasis—TP53—peripheral nervous system neoplasm	2.53e-05	0.000376	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.51e-05	0.000373	CbGpPWpGaD
Cyclosporine—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.49e-05	0.000371	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—NRAS—peripheral nervous system neoplasm	2.47e-05	0.000368	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	2.47e-05	0.000368	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.46e-05	0.000366	CbGpPWpGaD
Cyclosporine—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.46e-05	0.000365	CbGpPWpGaD
Cyclosporine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.45e-05	0.000131	CcSEcCtD
Cyclosporine—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.45e-05	0.000364	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	2.44e-05	0.000363	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.44e-05	0.000362	CbGpPWpGaD
Cyclosporine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.43e-05	0.00013	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.43e-05	0.000361	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—HRAS—peripheral nervous system neoplasm	2.42e-05	0.00036	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—PTPN11—peripheral nervous system neoplasm	2.39e-05	0.000356	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—GNAS—peripheral nervous system neoplasm	2.37e-05	0.000353	CbGpPWpGaD
Cyclosporine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.37e-05	0.000127	CcSEcCtD
Cyclosporine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.36e-05	0.000126	CcSEcCtD
Cyclosporine—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	2.35e-05	0.00035	CbGpPWpGaD
Cyclosporine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.35e-05	0.000126	CcSEcCtD
Cyclosporine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.35e-05	0.000126	CcSEcCtD
Cyclosporine—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	2.35e-05	0.000349	CbGpPWpGaD
Cyclosporine—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.35e-05	0.000349	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	2.33e-05	0.000347	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.33e-05	0.000347	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.33e-05	0.000347	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.31e-05	0.000344	CbGpPWpGaD
Cyclosporine—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.31e-05	0.000123	CcSEcCtD
Cyclosporine—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.3e-05	0.000342	CbGpPWpGaD
Cyclosporine—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.27e-05	0.000122	CcSEcCtD
Cyclosporine—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.27e-05	0.000338	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	2.26e-05	0.000336	CbGpPWpGaD
Cyclosporine—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.24e-05	0.000334	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	2.24e-05	0.000333	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	2.23e-05	0.000333	CbGpPWpGaD
Cyclosporine—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.23e-05	0.000332	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.23e-05	0.000332	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—PTPN11—peripheral nervous system neoplasm	2.21e-05	0.000329	CbGpPWpGaD
Cyclosporine—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.2e-05	0.000328	CbGpPWpGaD
Cyclosporine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.2e-05	0.000118	CcSEcCtD
Cyclosporine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.19e-05	0.000117	CcSEcCtD
Cyclosporine—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	2.17e-05	0.000323	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—ENO2—peripheral nervous system neoplasm	2.16e-05	0.000321	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	2.15e-05	0.000321	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—AKT1—peripheral nervous system neoplasm	2.13e-05	0.000318	CbGpPWpGaD
Cyclosporine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.13e-05	0.000114	CcSEcCtD
Cyclosporine—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.13e-05	0.000317	CbGpPWpGaD
Cyclosporine—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.13e-05	0.000114	CcSEcCtD
Cyclosporine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.1e-05	0.000113	CcSEcCtD
Cyclosporine—PPIA—Disease—ERBB2—peripheral nervous system neoplasm	2.1e-05	0.000313	CbGpPWpGaD
Cyclosporine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.09e-05	0.000312	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	2.07e-05	0.000308	CbGpPWpGaD
Cyclosporine—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.04e-05	0.000109	CcSEcCtD
Cyclosporine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.04e-05	0.000109	CcSEcCtD
Cyclosporine—Rash—Epirubicin—peripheral nervous system neoplasm	2.03e-05	0.000108	CcSEcCtD
Cyclosporine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.03e-05	0.000108	CcSEcCtD
Cyclosporine—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.02e-05	0.000301	CbGpPWpGaD
Cyclosporine—Headache—Epirubicin—peripheral nervous system neoplasm	2.01e-05	0.000108	CcSEcCtD
Cyclosporine—FKBP1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.98e-05	0.000294	CbGpPWpGaD
Cyclosporine—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.98e-05	0.000294	CbGpPWpGaD
Cyclosporine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.97e-05	0.000105	CcSEcCtD
Cyclosporine—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.94e-05	0.000288	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	1.94e-05	0.000288	CbGpPWpGaD
Cyclosporine—Nausea—Epirubicin—peripheral nervous system neoplasm	1.91e-05	0.000102	CcSEcCtD
Cyclosporine—PPP3CA—Immune System—ERBB2—peripheral nervous system neoplasm	1.89e-05	0.000282	CbGpPWpGaD
Cyclosporine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.89e-05	0.000101	CcSEcCtD
Cyclosporine—FKBP1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.88e-05	0.00028	CbGpPWpGaD
Cyclosporine—Rash—Doxorubicin—peripheral nervous system neoplasm	1.88e-05	0.0001	CcSEcCtD
Cyclosporine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.87e-05	0.0001	CcSEcCtD
Cyclosporine—Headache—Doxorubicin—peripheral nervous system neoplasm	1.86e-05	9.97e-05	CcSEcCtD
Cyclosporine—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	1.82e-05	0.000271	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.81e-05	0.000269	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.8e-05	0.000268	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.8e-05	0.000268	CbGpPWpGaD
Cyclosporine—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.77e-05	9.45e-05	CcSEcCtD
Cyclosporine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.76e-05	0.000262	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	1.75e-05	0.00026	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—ERBB2—peripheral nervous system neoplasm	1.75e-05	0.00026	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.74e-05	0.000259	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.73e-05	0.000257	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	1.71e-05	0.000255	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PTPN11—peripheral nervous system neoplasm	1.71e-05	0.000255	CbGpPWpGaD
Cyclosporine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.7e-05	0.000253	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	1.69e-05	0.000251	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.68e-05	0.00025	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.67e-05	0.000248	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.66e-05	0.000247	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.65e-05	0.000245	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	1.64e-05	0.000245	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	1.62e-05	0.000241	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.62e-05	0.000241	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.61e-05	0.000239	CbGpPWpGaD
Cyclosporine—PPIA—Disease—NRAS—peripheral nervous system neoplasm	1.6e-05	0.000238	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—AKT1—peripheral nervous system neoplasm	1.6e-05	0.000238	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.58e-05	0.000235	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	1.56e-05	0.000232	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.56e-05	0.000232	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.55e-05	0.00023	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	1.54e-05	0.000229	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.52e-05	0.000227	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.5e-05	0.000223	CbGpPWpGaD
Cyclosporine—PPIA—Disease—MYC—peripheral nervous system neoplasm	1.49e-05	0.000222	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.48e-05	0.00022	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.46e-05	0.000217	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.45e-05	0.000216	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—NRAS—peripheral nervous system neoplasm	1.44e-05	0.000214	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	1.43e-05	0.000213	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.43e-05	0.000212	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.41e-05	0.00021	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.4e-05	0.000208	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	1.4e-05	0.000208	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	1.37e-05	0.000204	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	1.37e-05	0.000204	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.37e-05	0.000203	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—ERBB2—peripheral nervous system neoplasm	1.35e-05	0.000202	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.35e-05	0.000201	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	1.34e-05	0.0002	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.34e-05	0.0002	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—NRAS—peripheral nervous system neoplasm	1.33e-05	0.000198	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.33e-05	0.000198	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.32e-05	0.000196	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.31e-05	0.000194	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.3e-05	0.000194	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.3e-05	0.000194	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	1.29e-05	0.000192	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.27e-05	0.000189	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.25e-05	0.000186	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.24e-05	0.000185	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—MYC—peripheral nervous system neoplasm	1.24e-05	0.000184	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	1.22e-05	0.000182	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.22e-05	0.000182	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.22e-05	0.000182	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.21e-05	0.000179	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.2e-05	0.000179	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.2e-05	0.000179	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.2e-05	0.000179	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.19e-05	0.000178	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.19e-05	0.000177	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.17e-05	0.000175	CbGpPWpGaD
Cyclosporine—PPIA—Disease—HRAS—peripheral nervous system neoplasm	1.17e-05	0.000174	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.17e-05	0.000174	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.15e-05	0.000172	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.15e-05	0.000171	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.15e-05	0.000171	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.15e-05	0.000171	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.14e-05	0.00017	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.14e-05	0.00017	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.13e-05	0.000169	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	1.12e-05	0.000167	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.11e-05	0.000165	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.11e-05	0.000165	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.1e-05	0.000163	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.08e-05	0.000161	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.07e-05	0.000159	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—HRAS—peripheral nervous system neoplasm	1.05e-05	0.000157	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	1.05e-05	0.000156	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.05e-05	0.000156	CbGpPWpGaD
Cyclosporine—PPIA—Disease—AKT1—peripheral nervous system neoplasm	1.03e-05	0.000154	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.03e-05	0.000154	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—NRAS—peripheral nervous system neoplasm	1.03e-05	0.000153	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	1.02e-05	0.000152	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.02e-05	0.000151	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	9.99e-06	0.000149	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—AKT1—peripheral nervous system neoplasm	9.95e-06	0.000148	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	9.81e-06	0.000146	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—HRAS—peripheral nervous system neoplasm	9.73e-06	0.000145	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MYC—peripheral nervous system neoplasm	9.6e-06	0.000143	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.49e-06	0.000141	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.31e-06	0.000139	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—AKT1—peripheral nervous system neoplasm	9.3e-06	0.000138	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	9.25e-06	0.000138	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	9.17e-06	0.000136	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	9.08e-06	0.000135	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	9e-06	0.000134	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	8.85e-06	0.000132	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	8.73e-06	0.00013	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.67e-06	0.000129	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	8.64e-06	0.000129	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.61e-06	0.000128	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	8.6e-06	0.000128	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—AKT1—peripheral nervous system neoplasm	8.59e-06	0.000128	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.24e-06	0.000123	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	8.12e-06	0.000121	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	7.9e-06	0.000118	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	7.84e-06	0.000117	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	7.71e-06	0.000115	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—HRAS—peripheral nervous system neoplasm	7.54e-06	0.000112	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	7.52e-06	0.000112	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	7.48e-06	0.000111	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	7.27e-06	0.000108	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	7.26e-06	0.000108	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	7.24e-06	0.000108	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.22e-06	0.000107	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	7.21e-06	0.000107	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.14e-06	0.000106	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.12e-06	0.000106	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	7.03e-06	0.000105	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	6.9e-06	0.000103	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.81e-06	0.000101	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.72e-06	0.0001	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	6.68e-06	9.94e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—AKT1—peripheral nervous system neoplasm	6.66e-06	9.91e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	6.63e-06	9.86e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	6.52e-06	9.7e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	6.51e-06	9.68e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—AKT1—peripheral nervous system neoplasm	6.41e-06	9.54e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.37e-06	9.48e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	6.28e-06	9.34e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.22e-06	9.25e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	6.14e-06	9.14e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	6.13e-06	9.12e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	6.09e-06	9.06e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.01e-06	8.95e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.86e-06	8.72e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.81e-06	8.64e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	5.77e-06	8.59e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	5.74e-06	8.54e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	5.72e-06	8.52e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	5.63e-06	8.38e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.52e-06	8.22e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.28e-06	7.86e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	5.25e-06	7.81e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	5.13e-06	7.63e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	5.03e-06	7.48e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	5e-06	7.44e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MYC—peripheral nervous system neoplasm	4.89e-06	7.27e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.75e-06	7.07e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	4.71e-06	7.01e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.67e-06	6.95e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.66e-06	6.94e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	4.63e-06	6.88e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.59e-06	6.82e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.02e-06	5.98e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	3.84e-06	5.71e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.83e-06	5.7e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	3.78e-06	5.62e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.78e-06	5.62e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	3.62e-06	5.39e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	3.39e-06	5.04e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.15e-06	4.69e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.08e-06	4.59e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.02e-06	4.5e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	2.84e-06	4.22e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	2.7e-06	4.01e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	2.5e-06	3.72e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	2.48e-06	3.68e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.79e-06	2.66e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.55e-06	2.31e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.38e-06	2.06e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.35e-06	2.01e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.27e-06	1.89e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.26e-06	1.88e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	8.32e-07	1.24e-05	CbGpPWpGaD
